Please login to the form below
Zoetis
This page shows the latest Zoetis news and features for those working in and with pharma, biotech and healthcare.
Pfizer mulling product sale to streamline ops; sources
unit Zoetis to deal with accretion and dilution.
Latest news
-
Sanofi and Boehringer Ingelheim complete €21.8bn asset swap
Boehringer's animal health unit is now the second-largest in the business, only surpassed by Pfizer spin-out Zoetis.
-
Pfizer decides against long-discussed break-up
The company has been deliberating a split since it span out its animal health division via an initial public offering (IPO) into stand-alone company Zoetis, and in particular had been
-
Sanofi and Boehringer agree asset swap deal
The veterinary sector saw Pfizer spin out its Zoetis unit - the biggest player in the market - in 2011, while Elanco bought Novartis' unit last year to claim the second spot ahead
-
UK government fines GSK over 'pay-for-delay' deals
other subsidiaries including Xellia Pharma and Zoetis Products LLC.
-
Sanofi and Boehringer in $20bn asset swap negotiations
Boehringer, meanwhile, would become the second-largest animal health company after Pfizer spin-out Zoetis if the deal goes through, with pro forma sales of 3.8bn in 2015 putting it
More from news
Approximately 2 fully matching, plus 26 partially matching documents found.
Latest Intelligence
-
Pharma deals during November 2014
form of Zoetis who this month acquired Abbott's animal health business for $255m. ... Bill Ackman, a Valeant investor, now owns 8.5% of Zoetis, which may pave the way for a potential deal.
-
Pharma deals during April 2014
spot in terms of sales, second only to Zoetis.
-
Pharma deals during January 2014
Several major pharma firms are deciding where to focus their business interests with Pfizer spinning out Zoetis for its animal health interests and Abbott doing the same for its pharma business,
-
Pharma deals during December 2012
The next major event in the animal health deal calendar will probably be the IPO of Pfizer's animal health business (named in the IPO documents as Zoetis) which had 2011
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Animal Healthcare Market is poised to cross USD 36 billion by 2024
Leading companies in the industry include, Zoetis, Elanco, Bayer, Boehringer Ingelheim, Virbac, Merck, Ceva Sante Animale, Vetoquinol, Phirbo Animal Health.
-
Equine Veterinary Therapeutics Market Growth, Trends, Absolute Opportunity and Value Chain 2016-2026
Request to View TOC@ . Market: Key Players. Some of the players in equine veterinary therapeutics market includes: Merck animal heath, Affymetrix, Elanco animal heath, Zoetis (Pfizer Animal Health), Equine Health
-
Canine Atopic Dermatitis Treatment Market to Register Significant Growth Globally During 2017-2027
policies. Some of the key players in the global Canine Atopic Dermatitis market are Elanco Animal Health, Zoetis, Boehringer Ingelheim, Virbac, Toray Industries, AB Science, Novartis and many others.
-
Rapidly Rising Instances of Canine Atopic Dermatitis Across the World to Push Revenues in the Global Market
Some of the key players in the global Canine Atopic Dermatitis market are Elanco Animal Health, Zoetis, Boehringer Ingelheim, Virbac, Toray Industries, AB Science, Novartis and many others.
-
Random42 Scientific Communication
Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for over 550 product launches for the world's leading pharmaceutical, biotechnology and medical companies and won over 150
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Featured jobs
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Medical Writers
-
Competitive Salary and Benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Senior Medical Writer
-
Great salary and benefits
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Associate Director
-
£75, 000-90, 000
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Medical/ Scientific Director
-
Salary TBC
-
Account Director
-
Excellent benefits
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Senior Systematic Review Analyst - Oxford
-
Negotiable
-
Senior Medical Writer
-
Competitive Salary
Subscribe to our email news alerts
- Behaviour change: what is the buzz all about?
- Worldwide Clear Aligner Market to grow at a CAGR of 16.15% By 2023
- Worldwide Prenatal and New-born Genetic Testing Market Set to Register 11.9% CAGR During 2018-2024
- Medical Biomimetics Market soaring at 5.5% CAGR to Hit USD 34.4 Billion By 2024
- Medical Marijuana Market to Soar at 36% CAGR to 2024
- Worldwide Medical Ultrasound Imaging Equipment Market to Witness Robust Expansion Throughout the Forecast Period 2018 – 2023
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
